Target intelligence / Profile preview

Natural cytotoxicity triggering receptor 2 ligands

Molecular classification
Receptor ligand, Other
01

Overview

“Natural cytotoxicity triggering receptor 2 ligands” refers collectively to the **ligands** that bind to **natural cytotoxicity triggering receptor 2 (NCR2 / NKp44)**, an activating receptor expressed mainly on human natural killer (NK) cells.[6][7][5] NCR2 itself is a type I transmembrane receptor with an extracellular Ig-like domain that associates with adaptor molecules to transduce activating signals, but “NCR2 ligands” is not a single, well-defined molecular entity; instead, multiple, structurally unrelated ligands on target cells (such as tumor cells, virus‑infected cells, or stressed cells, including a ligand described on astrocytes) can engage NKp44 and modulate NK cell cytotoxicity and cytokine production.[3][5][6] Because the query groups all ligands together rather than specifying one molecular species, it is not a properly canonical single target name and should be treated as an imprecise/aggregate term rather than a unique drug target.

Other names
Ligands of natural cytotoxicity receptor NKp44NKp44 ligandsNCR2 ligands
02

Biological functions

Immune responseSignal transductionCell deathOther
03

Disease associations

CancerInfectionInflammationOther

Beyond the preview

Go deeper on Natural cytotoxicity triggering receptor 2 ligands.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural cytotoxicity triggering receptor 2 ligands.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call